As with death and taxes, so it seems for rising drug costs, particularly in the United States. A frequently covered news story in 2015, rising drug costs are typically blamed on over-regulation by some and not enough regulation (and greed) by others. Either way, prescription-drug prices have risen by double digits for three consecutive years, according to Truveris, a digital health company aimed at lowering costs. According to the Wall Street Journal, ‘the prices of 19 brand name prescription drugs for skin conditions … increased more than 500% from 2009 to 2015.’
Despite US congressional hearings and calls for the US Food & Drug Administration (FDA) to investigate price gouging of medicines, prices will continue to rise in 2016
Those are shocking increases, yet despite US congressional hearings and calls for the US Food & Drug Administration (FDA) to investigate price gouging of medicines, prices will continue to rise in 2016.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.